Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study

INTRODUCTION: Major depressive disorder (MDD) is more likely to resist to usual treatment when it is associated with post-traumatic stress disorder (PTSD). Capitalizing on the effect of ketamine in both treatment-resistant depression (TRD) and PTSD, we conducted a study in order to assess the effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothärmel, Maud, Benosman, Cherifa, El-Hage, Wissam, Berjamin, Caroline, Ribayrol, Diane, Guillin, Olivier, Gaillard, Raphaël, Berkovitch, Lucie, Moulier, Virginie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305073/
https://www.ncbi.nlm.nih.gov/pubmed/35873243
http://dx.doi.org/10.3389/fpsyt.2022.865466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305073/
https://www.ncbi.nlm.nih.gov/pubmed/35873243
http://dx.doi.org/10.3389/fpsyt.2022.865466

Ejemplares similares